Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Phase I/II trial for TG-100-115 in heart attack patients

Jan. 11, 2005

Platelet antiaggregatory agents disclosed by Daiichi

Jan. 10, 2005

Afelimomab reduces mortality due to severe sepsis

Jan. 5, 2005

New eNOS expression enhancers under investigation at Aventis

Jan. 5, 2005

AtheroGenics proposes amendments to ARISE trial of AGI-1067

Jan. 5, 2005

Enrollment completed in phase II congestive heart failure study of oxypurinol

Jan. 4, 2005

New data from the STRIDE-4 trial supports the use of Thelin in PAH

Jan. 4, 2005

COX-2-derived prostacyclin is atheroprotective in female mice

Dec. 30, 2004

Ventavis approved for PAH

Dec. 30, 2004

A phase III trial confirms the therapeutic benefits of RSD-1235 in AF

Dec. 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...